A roundup: a Harvard review finds Parkinson's and Alzheimer's have been linked to reduced cancer risk through shared biological pathways, and an Oncogene study reports rats given 21 weeks of zinc deficiency plus low-dose NMBA had a 66.7 percent chance of esophageal carcinoma.
Section archive
Esophageal Cancer
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Food
Strawberries may help stop cancer
Ohio State researchers gave 36 people about two ounces of freeze-dried strawberries daily for six months; 29 showed a drop in the histological grade of precancerous esophageal lesions. Lead author Tong Chen calls the data preliminary.
Food
Eating red meat may boost risk of esophageal cancer, stomach cancer
People in the highest fifth of red meat intake were 79 percent more likely to develop esophageal squamous cell carcinoma, a National Cancer Institute analysis found, and the highest DiMeIQx intake carried 44 percent higher gastric cardia cancer risk. The study is observational.
Nutrition
Alcohol boosts pancreatic cancer risk - study
A meta-analysis of 21 case-control and 11 cohort studies in the International Journal of Cancer found people drinking three or more drinks a day were 22 percent more likely to develop pancreatic cancer. Separately, British scientists rated alcohol the most harmful drug overall.
Drug
Anti-osteoporosis drugs bisphosphonates boost esophageal cancer risk
A UK case-control study in the British Medical Journal found people who took oral bisphosphonates over five years, or had more than 10 prescriptions, were twice as likely to have esophageal cancer as those who took less or none. The drugs showed no link to colorectal cancer.
Drug
Osteoporosis drugs bisphosphonates linked to esophageal cancer
A UK case-control study in the BMJ found people taking oral bisphosphonates for more than five years, with 10 or more prescriptions, were twice as likely to receive an esophageal cancer diagnosis — about 2 extra cases per 1,000 over five years. Stomach and colorectal risk did not shift.
6 stories